Study Designs
Stats & Significance
Lab Testing Fundamentals
Clinical Case Studies I
Clinical Case Studies II
100

This type of study selects a defined group of people and follows them over time to monitor a specific outcome

Cohort Study

100

This numerical value is the standard cut-off; results equal to or less than this are considered statistically significant.

0.05 (P-value)

100

Defined as the likelihood of an abnormal test result in persons known to have the disease (True Positives / All with disease)

Sensitivity

100

The Women's Health Initiative RCT was stopped early after finding that Estrogen plus Progestin increased risks for breast cancer, stroke, and this primary outcome

Coronary Heart Disease

100

A retrospective cohort study of over 500,000 children in Denmark provided strong evidence against the link between autism and this vaccine

MMR (Measles, Mumps, and Rubella) vaccine

200

This design compares individuals who already have a diagnosis to a matched group of individuals who do not have the diagnosis.

Case-Control Study

200

A 95% Confidence Interval (CI) is generally considered not statistically significant if it crosses this number.

1

200

This is the likelihood of a normal test result in persons known to be disease-free.

Specificity

200

While increasing cardiovascular risks, the Women's Health Initiative found that hormone therapy actually decreased the risk of this

hip fractures

200

This antiviral medication was shown in an RCT to significantly reduce the transmission of genital herpes to susceptible partners

Valacyclovir

300

This statistical analysis merges data from several smaller studies to yield a more robust result in a larger population

Meta-Analysis

300

This metric represents the number of patients a clinician must treat for one person to benefit.

NNT (Number Needed to Treat)

300

This term describes the likelihood of an abnormal result in a person known not to have the disease, calculated as "1 - specificity."

False-Positive rate

300

Meta-analyses of passive smoking showed causality was bolstered by this finding, where higher levels of exposure correlated with higher risk.

dose-response relationship

300

According to a record review of large health systems, this advanced imaging test saw a massive 57% annual increase between 1996 and 2010.

PET scan

400

This "gold standard" study design involves randomization and a control group, ideally with both patients and researchers "blinded.

Randomized Controlled Trial (RCT)

400

If a p-value is above 0.05, the results are technically insignificant, but the sources state they may suggest this.

trend

400

Laboratory data can never replace these two primary clinical tools and must be interpreted in light of the clinical setting.

history and physical examination

400

In studies of smoking, factors like socioeconomic group or diet might mask the true relationship; these are known as this

confounding factors

400

To prevent one case of HSV-2 infection in a susceptible partner, one would need to treat this many people for a year.

38

500

What observational studies are cused when an RCT is not funded, practical, or ethical.

cohort or case-control designs

500

This risk measure provides a percentage of improvement (e.g., a 50% reduction in risk) rather than the raw number of lives saved

Relative Risk

500

Choosing a test cutoff that yields high sensitivity will typically result in this level of specificity.

low specificity

500

This specific type of study was used to evaluate passive smoking in the workplace or among spouses of smokers.

Cohort Study

500

This country was the site of a massive retrospective cohort study of over 500,000 children regarding the MMR vaccine

Denmark

M
e
n
u